Bisacodyl
- Product NDC
- 11534-013
- 11-digit product format
- 115340013
- Labeler code
- 11534
- Product ID
- 11534-013_6be65bdd-e94a-4682-9977-043741174c59
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Bisacodyl
- Dosage form
- TABLET, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Sunrise Pharmaceutical Inc
- Application
- part334
- Marketing category
- OTC MONOGRAPH NOT FINAL
- Marketing start
- 2005-07-08
- Marketing end
- 0000-00-00
- Substance
- BISACODYL
- Active strength
- 5 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 11534-013-01 | Bisacodyl | 100 in 1 BOTTLE | TABLET, DELAYED RELEASE | 100 | | 3 |
| 11534-013-03 | Bisacodyl | 1000 in 1 BOTTLE | TABLET, DELAYED RELEASE | 1000 | | 3 |
| 11534-013-25 | Bisacodyl | 25 in 1 BOTTLE | TABLET, DELAYED RELEASE | 25 | | 3 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| BISACODYL | ACTIVE INGREDIENT | 10X0709Y6I | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| BISACODYL | ACTIVE MOIETY | 10X0709Y6I | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CALCIUM SULFATE | INACTIVE INGREDIENT | WAT0DDB505 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CARNAUBA WAX | INACTIVE INGREDIENT | R12CBM0EIZ | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CELLULOSE, MICROCRYSTALLINE | INACTIVE INGREDIENT | OP1R32D61U | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| CROSCARMELLOSE SODIUM | INACTIVE INGREDIENT | M28OL1HH48 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| FD&C YELLOW NO. 6 | INACTIVE INGREDIENT | H77VEI93A8 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| HYPROMELLOSE 2910 (5 MPA.S) | INACTIVE INGREDIENT | R75537T0T4 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| KAOLIN | INACTIVE INGREDIENT | 24H4NWX5CO | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| LACTOSE | INACTIVE INGREDIENT | J2B2A4N98G | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| MAGNESIUM STEARATE | INACTIVE INGREDIENT | 70097M6I30 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER (1:1) TYPE A | INACTIVE INGREDIENT | NX76LV5T8J | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| MINERAL OIL | INACTIVE INGREDIENT | T5L8T28FGP | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| POLYETHYLENE GLYCOL | INACTIVE INGREDIENT | 3WJQ0SDW1A | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| PROPYLENE GLYCOL | INACTIVE INGREDIENT | 6DC9Q167V3 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| STEARIC ACID | INACTIVE INGREDIENT | 4ELV7Z65AP | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
| TRIETHYL CITRATE | INACTIVE INGREDIENT | 8Z96QXD6UM | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 11534-013 | BISACODYL TABLET, DELAYED RELEASE [SUNRISE PHARMACEUTICAL INC] | 3 | Legacy NDC, 3 package rows | 20110815_d497e5a6-625a-49cb-bccb-a5e7da89b451.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 11534-013-01 | 11534001301 | 100 in 1 BOTTLE | Historical |
| 11534-013-03 | 11534001303 | 1000 in 1 BOTTLE | Historical |
| 11534-013-25 | 11534001325 | 25 in 1 BOTTLE | Historical |